Summary by Futu AI
On June 20, 2024, Lilly Endowment Inc completed a sale of Eli Lilly and Co (LLY) common stock. The transactions were executed in the open market with a total of 9,671 shares sold. The sales occurred at prices ranging from $902.253 to $904.245 per share, resulting in a total market value of approximately $8.73 million. Following these transactions, Lilly Endowment Inc's direct holdings in Eli Lilly and Co amounted to 97,574,139 shares of common stock.